Eliot Forster - Chief Executive Officer @ Levicept

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Chief Executive Officer
Primary Organization
Levicept

Location Sandwich, Kent, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Eliot Forster is based out of Sandwich, Kent and is the Chief Executive Officer of Levicept. Eliot previously worked at F-star Therapeutics as a Chief Executive Officer. Eliot Forster attended Henley Business School.

Jobs

Number of Current Jobs

Number of Past Jobs

Eliot Forster

is the

Chief Executive Officer

Levicept

. Additionally,

Eliot Forster

has had

past jobs including

Chief Executive Officer

F-Star Therapeutics

Levicept Chief Executive OfficerNov 23, 2023

Organization Name	Title At Company	Start Date	End Date
F-Star Therapeutics	Chief Executive Officer	Oct 1, 2018	Mar 2023
Immunocore	CEO	Jan 2015	Feb 8, 2018
Creabilis	CEO	May 2010	Jan 2015

Board and Advisor Roles

Number of Current Board & Advisor Roles

Eliot Forster

holds

board and advisor roles including

Non Executive Chair

Tessellate BIO

Board of Director

Tessellate BIO

, and

Non-Executive Chairman

Avacta Group

Tessellate BIO Non Executive ChairSep 2023
Tessellate BIO Board of Director2023
Avacta Group Non-Executive ChairmanJun 1, 2018

Related Hubs

Hub Name	CB Rank (Hub)
United Kingdom Biotechnology Companies	5,497
Medical Device Companies With Fewer Than 50 Employees (Top 10K)	3,628
Europe Early Stage Companies With More Than $1M in Revenue	17,714
Private Kent Companies	8,986
Medical Device Companies With Less Than $10M in Revenue (Top 10K)	5,036
Europe Early Stage Companies With Less Than $10M in Revenue	25,888
United Kingdom Early Stage Companies With More Than $1M in Revenue	41,474
Biotechnology Early Stage Companies With Less Than $500M in Revenue	25,873
Medical Device Early Stage Companies With Less Than $10M in Revenue	54,739
Medical Device Early Stage Companies With Less Than $50M in Revenue	48,757